Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review)
Molecular Medicine Reports · 18.03.2025 · 31 (5) · 1-17
DOI: 10.3892/mmr.2025.13495 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, online erschienen am 18.03.2025. Verfasst von Li Yan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Genomics, Proteomics. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The application of multi‑omics methodologies, encompassing genomics, transcriptomics, proteomics, metabolomics and integrative genomics, has markedly enhanced the understanding of prostate cancer (PCa). These methods have facilitated the identification of molecular pathways and biomarkers crucial for the early detection, prognostic evaluation and personalized treatment of PCa. Studies using multi‑omics technologies have elucidated how alterations in gene expression and protein interactions contribute to PCa progression and treatment resistance. Furthermore, the integration of multi‑omics data has been used in the identification of novel therapeutic targets and the development of innovative treatment modalities, such as precision medicine. The evolving landscape of multi‑omics research holds promise for not only deepening the understanding of PCa biology but also for fostering the development of more effective and tailored therapeutic interventions, ultimately improving patient outcomes. The present review aims to synthesize current findings from multi‑omics studies associated with PCa and to assess their implications for the improvement of patient management and therapeutic outcomes. The insights provided may guide future research directions and clinical practices in the fight against PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China.
Zitieren
APA
Yan, L., Su, P., & Sun, X. (2025). Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review). Molecular Medicine Reports, 31(5), 1-17. https://doi.org/10.3892/mmr.2025.13495
Vancouver
Yan L, Su P, Sun X. Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review). Molecular Medicine Reports. 2025;31(5):1-17. doi:10.3892/mmr.2025.13495
BibTeX
@article{Yan2025,
author = {Yan, Li and Su, Pengxiao and Sun, Xiaoke},
title = {Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review)},
journal = {Molecular Medicine Reports},
year = {2025},
volume = {31},
number = {5},
pages = {1--17},
doi = {10.3892/mmr.2025.13495}
}
EUVIMED